Announcements

Office of Sponsored Projects Administration (OSPA) will continue to perform all business activities as usual. OSPA personnel are working remotely and continue to provide full sponsored project support and services. For Federal agency responses to COVID-19, please see:   https://www.cogr.edu/institutional-and-agency-responses-covid-19-and-additional-resources 

NIH has issued NOT-OD-20-031 to clarify the underrepresented populations eligible for Diversity Supplements.

To ensure the best delivery of services and to facilitate submission of the highest quality proposals with the highest probability of success, OSPA is putting into effect a new submission deadline for sponsored project proposals to external funders.

For letters of institutional support towards grant applications that (1) require an official signature from the VPR, or (2) commit the Office of Research financially to an award, we are standardizing the process. In addition, this streamlined process ensures that leadership within Colleges and Centers are aware of the request, and that these relevant university offices have been involved in decisions of financial support towards the application.

A Resumption of Operations at NSF page has been published with information on grant and cooperative agreement-related policy and system issues.

Effective 01/22/19, the threshold for which UG requirement apply will increase to $10,000 per order value.

Emily will provide assistance with current Clinicaltrial.gov database issues as well as training for new or existing registries.

NIH recently announced that they are contacting PIs who have duplicate accounts in Common. Some PIs were contacted recently and more will receive emails from NIH in the next two weeks.

Reminder: National Institutes of Health (NIH) Applications Must Be Complete and Compliant With NIH Policy and Application Instructions At Time Of Submission (NOT-OD-17-105)

Revised F&A Rates for Industry-funded Clinical Trials will be 22.3%, and Federally-funded and Flow-through Clinical Trials will be 53% effective 7/1/17